Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Begins Global Clinical Study of Investigational Pericardial Surgical Aortic Heart Valve

[Thomson Reuters ONE] – MINNEAPOLIS – October 28, 2014 – Medtronic, Inc. (NYSE: MDT) today announced it has initiated the PERIGON ( PERI cardial Sur G ical A O rtic Valve Replaceme N . . . → Read More: Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Begins Global Clinical Study of Investigational Pericardial Surgical Aortic Heart Valve Similar Articles: Market Update: Medtronic Inc (NYSE:MDT) – Medtronic seeks EU approval for $43 bln Covidien deal Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S. Medtronic Inc (NYSE:MDT) | Medtronic settles heart valve patent fight with Edwards
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.